CN Stock MarketDetailed Quotes
002603 Shijiazhuang Yiling Pharmaceutical
- 16.31
- +0.14+0.87%
Market Closed Dec 27 15:00 CST
27.25BMarket Cap183.26P/E (TTM)
16.39High16.08Low131.79KlotVolume16.20Open16.17Pre Close214.31MTurnover0.96%Turnover Ratio20.16P/E (Static)1.67BShares24.1752wk High2.37P/B22.45BFloat Cap14.1652wk Low17.79Limit Up1.38BShs Float53.16Historical High14.55Limit Down1.92%Amplitude4.79Historical Low0.30Dividend TTM16.26Avg Price53.51KlotAsk1.84%Div YieldTTM100Lot Size74.77KlotBid
Shijiazhuang Yiling Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -15.41%907.31M | -30.28%1.22B | 14.88%1.19B | -50.61%940.51M | -39.08%1.07B | 1.93%1.76B | -19.89%1.04B | 91.33%1.9B | 71.88%1.76B | -14.99%1.72B |
| Transactional financial assets | -96.19%9M | ---- | -91.87%113.4M | -60.27%205.97M | -7.32%236.01M | 287.81%404.67M | 794.98%1.4B | 837.86%518.38M | 362.36%254.66M | 91.05%104.35M |
| Notes receivable and accounts receivable | 11.67%2.78B | 22.17%2.75B | 32.22%2.56B | 39.29%2.41B | 24.53%2.49B | 11.34%2.25B | -8.33%1.94B | 7.21%1.73B | 12.92%2B | 16.11%2.02B |
| -Notes receivable | ---- | ---- | ---- | --4M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts receivable | 11.67%2.78B | 22.17%2.75B | 32.22%2.56B | 39.05%2.4B | 24.53%2.49B | 11.34%2.25B | -8.33%1.94B | 7.21%1.73B | 12.92%2B | 16.11%2.02B |
| Other receivables (including interest and dividends) | 299.75%26.15M | 63.31%10.35M | -5.78%5.92M | -3.88%5.35M | -21.93%6.54M | -10.08%6.34M | -32.02%6.28M | -24.54%5.57M | -46.50%8.38M | -59.17%7.05M |
| -Other receivable | ---- | 63.31%10.35M | ---- | ---- | ---- | -10.08%6.34M | ---- | -24.54%5.57M | ---- | -59.17%7.05M |
| Advance payment | -36.56%148.35M | -34.24%139.82M | -61.76%112.27M | -78.75%109.71M | -42.77%233.85M | 13.25%212.62M | 47.76%293.61M | 129.89%516.33M | 51.33%408.63M | -18.39%187.74M |
| Inventories | -20.02%1.94B | -23.68%1.92B | -29.10%2B | 21.61%2.46B | 44.26%2.43B | 28.38%2.51B | 68.59%2.82B | 20.87%2.02B | 3.91%1.68B | -2.26%1.96B |
| Receivable financing | 87.34%309.28M | 91.14%359.46M | -29.08%545.87M | -57.58%191.24M | -81.99%165.09M | -64.53%188.07M | 57.50%769.65M | -39.92%450.86M | 5.74%916.47M | -48.13%530.21M |
| Other current assets | -67.24%64.25M | 7.70%136.65M | -36.94%125.07M | 106.18%227.08M | 136.67%196.11M | 101.29%126.88M | -37.83%198.34M | -61.46%110.14M | -69.73%82.86M | -79.14%63.03M |
| Total current assets | -9.40%6.18B | -12.33%6.54B | -21.32%6.66B | -9.79%6.54B | -4.03%6.82B | 13.11%7.46B | 35.29%8.46B | 29.49%7.25B | 20.67%7.11B | -10.85%6.59B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -15.74%1.65B | -19.91%1.64B | -11.82%1.62B | 22.42%1.65B | 196,214.53%1.96B | 204,762.78%2.05B | 184,109.14%1.84B | 134,540.60%1.35B | 0.00%1M | 0.00%1M |
| Investment real estate | -12.89%23.36M | 5.81%23.85M | -16.99%19.29M | 6.32%24.82M | 9.89%26.82M | -4.67%22.54M | 0.55%23.24M | -3.80%23.35M | 45.38%24.4M | 135.58%23.64M |
| Long-term equity investment | -0.54%2.47M | -0.46%2.48M | -0.72%2.48M | -0.60%2.48M | -0.52%2.49M | -0.51%2.49M | --2.5M | --2.5M | --2.5M | --2.5M |
| Fixed assets | ---- | 9.60%5.94B | ---- | ---- | ---- | 41.05%5.42B | ---- | 22.78%4.63B | ---- | 15.39%3.84B |
| Constru in process | ---- | -14.42%1.34B | ---- | ---- | ---- | -24.74%1.57B | ---- | -19.27%1.57B | ---- | 12.61%2.08B |
| Construction materials | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -15.32%278.83K |
| Productive biological assets | -44.61%4.68M | -18.29%6.01M | -29.22%5.44M | -26.17%5.55M | -41.97%8.45M | -35.05%7.36M | -39.53%7.69M | -39.18%7.52M | -7.77%14.56M | -13.60%11.33M |
| Intangible assets | -4.02%721.23M | -3.93%728.74M | 2.60%736.34M | 2.69%743.52M | -3.87%751.42M | -2.14%758.54M | -8.57%717.66M | 9.62%724.01M | 58.75%781.71M | 63.53%775.16M |
| Development expenditure | 37.73%216.74M | 65.53%200.94M | 72.91%191.84M | 78.43%185.47M | -29.80%157.37M | -45.46%121.4M | -50.00%110.94M | -56.22%103.94M | -16.34%224.17M | -13.41%222.59M |
| Goodwill | -2.77%111.07M | -1.41%112.63M | --114.19M | --115.75M | --114.24M | --114.24M | ---- | ---- | ---- | ---- |
| Long deferred expense | 80.65%4.71M | 11.99%3.15M | 12.99%3.41M | 21.07%3.9M | 9.41%2.61M | 74.32%2.81M | 44.96%3.02M | 71.13%3.22M | -36.96%2.38M | -53.75%1.61M |
| Deferred tax assets | 24.95%147.52M | -1.28%163.93M | -31.27%176.37M | -35.46%183.58M | -28.98%118.07M | -11.55%166.06M | 51.17%256.62M | 143.10%284.43M | 32.75%166.25M | 46.56%187.75M |
| Usufruct assets | 30.43%23.78M | 27.00%25.37M | -6.20%19.35M | -8.23%20.53M | -3.43%18.23M | -6.66%19.97M | -16.66%20.63M | -20.41%22.38M | --18.88M | --21.4M |
| Other non current assets | -54.44%216.27M | -49.64%223.69M | -40.40%279.92M | -41.36%216.57M | -12.33%474.71M | -28.08%444.22M | -29.68%469.64M | -26.54%369.31M | -25.62%541.49M | -19.66%617.68M |
| Total non current assets | -1.69%10.43B | -2.64%10.41B | 7.00%10.47B | 14.85%10.44B | 35.80%10.61B | 37.29%10.7B | 28.79%9.79B | 24.43%9.09B | 10.19%7.81B | 13.96%7.79B |
| Total assets | -4.71%16.61B | -6.62%16.95B | -6.13%17.13B | 3.91%16.98B | 16.82%17.44B | 26.21%18.15B | 31.72%18.25B | 26.62%16.34B | 14.95%14.92B | 1.07%14.38B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -33.34%600.29M | -54.00%460.26M | -14.28%600.36M | 19.99%600.35M | 124.97%900.5M | 233.27%1B | 74.95%700.42M | -0.03%500.35M | -20.01%400.28M | -40.00%300.23M |
| Notes payable and accounts payable | 10.48%2.55B | -10.76%2.55B | -2.77%2.71B | 38.13%2.85B | -2.66%2.31B | 24.17%2.86B | 48.26%2.79B | 27.11%2.06B | 42.20%2.37B | 36.88%2.3B |
| -Notes payable | 40.74%592.56M | 11.65%629.84M | 20.12%756.69M | 24.42%722.79M | -26.66%421.03M | 89.62%564.12M | 284.93%629.95M | 851.96%580.92M | 201.12%574.04M | 11.54%297.51M |
| -Accounts payable | 3.72%1.96B | -16.27%1.92B | -9.45%1.95B | 43.51%2.12B | 5.02%1.89B | 14.46%2.3B | 25.70%2.16B | -5.15%1.48B | 21.66%1.8B | 41.66%2.01B |
| Contract liabilities | -18.42%173.51M | -35.19%272.85M | -71.78%337.12M | -74.00%287.52M | -63.41%212.69M | -13.82%421.03M | 168.76%1.19B | 266.68%1.11B | 43.11%581.34M | 10.55%488.53M |
| Salaries payable | -12.59%206.08M | -11.72%234.74M | -18.78%249.71M | -25.97%281.15M | 43.33%235.76M | 51.14%265.9M | 143.79%307.44M | 166.21%379.77M | -8.87%164.48M | -22.45%175.93M |
| Taxs payable | -49.94%90.13M | -31.99%104.25M | -52.40%138.65M | -64.16%169.89M | -47.01%180.03M | -36.67%153.29M | -5.81%291.3M | 284.71%474M | 80.30%339.74M | 158.96%242.03M |
| Other payable (including interest and dividends) | -42.65%306.33M | -41.83%535.54M | -63.62%31.9M | -64.09%43.2M | 1,798.32%534.12M | 74.86%920.6M | 227.16%87.69M | 188.69%120.29M | 15.25%28.14M | -56.82%526.49M |
| -Dividend payable | -39.34%274.08M | -39.64%501.21M | ---- | ---- | --451.8M | 65.67%830.35M | ---- | ---- | ---- | -58.00%501.21M |
| -Other payable | ---- | -61.96%34.32M | ---- | ---- | ---- | 257.02%90.24M | ---- | 188.69%120.29M | ---- | -2.02%25.28M |
| Non current liabilities due within one year | -31.57%3.02M | 3,741.99%203.69M | 30.94%203.05M | 32.46%206.62M | -65.91%4.41M | -97.52%5.3M | 1,053.91%155.07M | 1,061.69%155.98M | --12.93M | --213.62M |
| Other current liabilities | -42.70%10.34M | -14.92%10.57M | -64.06%13.54M | -78.53%11.43M | -94.60%18.05M | 36.70%12.42M | -83.99%37.66M | -75.39%53.21M | 51.97%334.19M | -98.27%9.08M |
| Total current liabilities | -10.34%3.94B | -22.43%4.37B | -22.96%4.29B | -8.32%4.45B | 3.82%4.39B | 32.40%5.64B | 61.86%5.56B | 63.83%4.85B | 32.78%4.23B | -9.15%4.26B |
| Current liabilities | ||||||||||
| Long term loan | -4.75%667.1M | 99.36%598.4M | 199.16%598.73M | 199.33%599.1M | 99.97%700.4M | 99.96%300.16M | -60.00%200.14M | -60.01%200.15M | -30.01%350.25M | -70.00%150.11M |
| Deferred tax liabilities | 1.26%127.3M | 3.33%128.89M | 1,718.48%130.53M | 1,171.38%130.14M | 10,231.62%125.72M | 10,286.46%124.74M | 420.39%7.18M | 637.85%10.24M | -11.13%1.22M | -12.31%1.2M |
| Long term deferred income | 5.44%375.59M | -3.72%364.69M | 8.49%358.93M | 5.18%352.37M | 0.30%356.22M | 7.79%378.78M | -6.31%330.85M | -6.38%335.02M | 3.46%355.17M | 1.21%351.41M |
| Lease liabilities | 63.43%20.69M | 63.85%21.75M | 5.62%14.83M | -13.08%13.01M | 434.32%12.66M | 422.92%13.27M | 165.46%14.04M | 19.49%14.97M | --2.37M | --2.54M |
| Total non current liabilities | -0.36%1.19B | 36.33%1.11B | 99.75%1.1B | 95.34%1.09B | 68.55%1.19B | 61.69%816.96M | -35.80%552.21M | -35.75%560.38M | -16.10%709M | -40.49%505.26M |
| Total liabilities | -8.21%5.13B | -15.00%5.49B | -11.87%5.39B | 2.42%5.54B | 13.11%5.59B | 35.50%6.46B | 42.31%6.11B | 41.17%5.41B | 22.53%4.94B | -13.95%4.76B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B |
| Capital reserve funds | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B |
| Surplus reserve funds | -0.00%936.76M | -0.00%936.76M | -0.00%936.76M | 0.00%936.76M | 23.40%936.77M | 23.40%936.77M | 23.40%936.77M | 23.40%936.76M | 28.56%759.11M | 28.56%759.11M |
| Retained profit | -5.10%6.56B | -3.32%6.54B | -5.31%6.81B | 8.63%6.51B | 32.44%6.91B | 39.27%6.76B | 50.12%7.19B | 39.08%5.99B | 19.86%5.22B | 18.52%4.85B |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Other composite income | 4.15%-6.06M | -5.92%-6.59M | 3.31%-6.65M | 8.38%-6.61M | 15.30%-6.32M | 27.91%-6.22M | 30.40%-6.87M | 25.67%-7.22M | 16.55%-7.47M | 6.80%-8.63M |
| Shareholders equity without minority interests | -2.97%11.5B | -1.92%11.48B | -3.14%11.75B | 4.73%11.45B | 18.75%11.86B | 21.69%11.7B | 27.03%12.14B | 20.54%10.93B | 11.56%9.98B | 10.68%9.62B |
| Minority interests | -116.68%-18.2M | -134.97%-15.56M | -354.34%-13.74M | -502.77%-11.73M | -1,009.75%-8.4M | -482.94%-6.62M | -235.65%-3.02M | -164.05%-1.95M | -71.29%923.14K | -58.95%1.73M |
| Total shareholder equity | -3.06%11.49B | -2.00%11.46B | -3.23%11.74B | 4.65%11.44B | 18.65%11.85B | 21.60%11.7B | 26.96%12.13B | 20.48%10.93B | 11.53%9.99B | 10.64%9.62B |
| Total liabilityies and equity | -4.71%16.61B | -6.62%16.95B | -6.13%17.13B | 3.91%16.98B | 16.82%17.44B | 26.21%18.15B | 31.72%18.25B | 26.62%16.34B | 14.95%14.92B | 1.07%14.38B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
